Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis: A Randomized Controlled Trial (ESWT)

Cairo University (CU)

Status: Not yet enrolling

Conditions: Palmar Fibromatosis

Treatments: Other: Extracorporeal Shock Wave Therapy; Other: traditional treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT06248866

P.T.REC/012/004965

Details and patient eligibility

About

this study will be conducted to investigate the effect of extracorporeal shock wave therapy on ultrasonography chnges In patients with palmar fibromatosis

Full description

Palmar fibromatosis, also known as Dupuytren's contracture, is a condition that affects the hand and fingers. It is characterized by the thickening and tightening of the fascia, a layer of connective tissue beneath the skin of the palm. This thickening and tightening can lead to the formation of nodules or cords that restrict the movement of the affected fingers. The treatment options for palmar fibromatosis vary depending on the severity of the condition and its impact on hand function. Mild cases may not require immediate treatment but should be regularly monitored. However, if the symptoms worsen or hinder hand function, there are several treatment options available. Extracorporeal shock wave therapy (ESWT) is a non-invasive physical therapy procedure that uses high-energy sound waves to treat various musculoskeletal conditions. It is commonly used to manage pain and promote healing in conditions such as plantar fasciitis, tendinitis, calcific tendinitis, and other similar disorders The ESWT has shown promising results in reducing pain, improving function, and promoting healing in various musculoskeletal conditions. sixty patients with palmar fibromatosis will be assigned randomly to two groups; first one will receive extracorporeal shock wave with traditional therapy and the other one will receive traditional therapy only

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with palmar fibromatosis.
• Adults aged 18 to 70 years.
• Patients of any stage of physiological change of the disease (nodules cords and contractures).

Exclusion criteria

• Patients with contraindications to extracorporeal shock wave therapy.
• Patients with a history of previous surgery for palmar fibromatosis.
• Patients with comorbidities or conditions that may affect the outcomes of the study.
• Patients of ganglions and palmar tendon fibrosis.
• Patients of sever and morbid obesity.
• End stage disease with psychological disturbance nature.
• Pregnant women.
• Cardiac and pulmonary unstable patients may affect results.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups

Extracorporeal Shock Wave Therapy

Experimental group

Description:

patients will receive Extracorporeal Shock Wave Therapy and traditional treatment three times a week for six weeks

Treatment:

Other: traditional treatment

Other: Extracorporeal Shock Wave Therapy

traditional treatment

Active Comparator group

Description:

patients will receive traditional treatment three times a week for six weeks

Treatment:

Other: traditional treatment